CP21R7
CP21R7 is potent GSK-3β inhibitor, with an IC50 of 1.8 nM; CP21R7 also shows inhibitory activitiy against PKCα, with an IC50 of 1900 nM.
Product Specifications
CAS Number
125314-13-8
Product Name Alternative
CP21
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
GSK-3
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CP21R7.html
Purity
99.74
Solubility
DMSO : ≥ 32 mg/mL
Smiles
O=C1C(C2=CN(C)C3=CC=CC=C23)=C(C4=CC(N)=CC=C4)C(N1)=O
Molecular Formula
C19H15N3O2
Molecular Weight
317.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Gong L, et al. Discovery of potent and bioavailable GSK-3beta inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20 (5) :1693-6.|[2]Patsch C, et al. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 2015 Aug;17 (8) :994-1003.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC203450L1 10 µg
CLC7 (CLCN7) (NM_001287) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
U1000-86M-FITC 200 µL
UBE2D1, CT (Ubiquitin-conjugating Enzyme E2-D1, Ubiquitin-protein Ligase D1, Ubiquitin Carrier Protein D1, UbcH5, Ubiquitin-conjugating Enzyme E2-17kD 1, Ubiquitin-conjugating Enzyme E2 (17) KB 1, UBC4/5 Homolog, Stimulator of Fe Transport, SFT, SFT, UBC5A, UBCH5, UBCH5A) (FITC) discontinued
Sign In for Pricing
View Details